3D Signatures Inc (DXD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:3D Signatures Inc (DXD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7889
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
3D Signatures Inc (3D Signatures) is a developer of diagnostic and prognostic products for cancers and neurological disorders. The company’s pipeline products include 3D Telo-PC a tool that is used to treat prostate cancer. It also provides 3D Telo-RS a diagnostic and prognostic tool used for the treatment of Hodgkin’s Lymphoma. 3D Signatures develops diagnostic and prognostic products that target neurological disorders and cancers. The company proprietary technology is used to analyze a specific part of an individual’s unique DNA. It conducts clinical trials using its 3D telomere analysis technology to stratify patients with cancers and Alzheimer‘s diseases. 3D Signatures is headquartered in Toronto, Ontario, Canada.

3D Signatures Inc (DXD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
3D Signatures Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
3D Signatures Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
3D Signatures Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
3D Signatures Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
3D Signatures Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
3D Signatures Inc, Medical Equipment, Deal Details 11
Partnerships 11
3D Signatures and Plicit Capital Enters into Licensing Agreement with Knight Therapeutics 11
Equity Offering 12
3D Signatures Raises USD1.3 Million in Private Placement of Units 12
3D Signatures Raises USD0.4 Million in Private Placement of Shares 13
3D Signatures Raises USD0.3 Million in Third and Final Tranche of Private Placement of Units 14
3D Signatures Raises Funds through Second Tranche of Private Placement of Units 16
3D Signatures Raises USD0.7 Million in Private Placement of Shares 18
Acquisition 19
Plicit Capital Acquires 3D Signatures in Reverse Takeover Transaction 19
3D Signatures Inc – Key Competitors 20
3D Signatures Inc – Key Employees 21
3D Signatures Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Strategy And Business Planning 23
Apr 18, 2017: 3D Signatures Announces Relocation to MaRS Discovery District in Toronto 23
Financial Announcements 24
Mar 01, 2018: 3D Signatures Reports Quarter Ended December 31, 2017 Financial Results 24
Nov 29, 2017: 3D Signatures Reports First Quarter Financial Results for Fiscal 2018 25
Oct 24, 2017: 3D Signatures Reports Financial Results for 2017 26
May 31, 2017: 3D Signatures Reports Third Quarter 2017 Financial Results 28
Mar 02, 2017: 3D Signatures Reports Second Quarter 2017 Financial Results 30
Corporate Communications 31
Feb 12, 2018: 3D Signatures Announces Board Changes 31
Oct 19, 2017: 3D Signatures Announces Changes to Its Board of Directors and Audit Committee 32
Oct 10, 2017: 3D Signatures Announces Change to Its Board of Directors 33
Aug 11, 2017: 3D Signatures Announces Change to its Board of Directors 34
May 05, 2017: 3D Signatures Announces Change to Its Board of Directors 35
Apr 11, 2017: 3D Signatures Announces Appointment of Dr. Kevin Little as Chief Scientific Officer 36
Feb 15, 2017: 3D Signatures Adds Medical Diagnostic Expert to Business Advisory Board 37
Jan 06, 2017: 3D Signatures Appoints Accomplished Healthcare Veteran as Chief Business Officer 38
Legal and Regulatory 39
May 31, 2018: 3D Signatures Announces Intention to File for Bankruptcy 39
Product News 40
Mar 14, 2017: 3D Signatures Makes Final Patent Payment 40
Other Significant Developments 41
Dec 01, 2017: 3D Signatures Announces Upsizing of $1,500,000 Private Placement, the Appointment of a New Director and Reports on AGM Results 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
3D Signatures Inc, Medical Equipment, Key Facts, 2017 2
3D Signatures Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
3D Signatures Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
3D Signatures Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
3D Signatures Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
3D Signatures Inc, Deals By Market, 2012 to YTD 2018 9
3D Signatures Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
3D Signatures and Plicit Capital Enters into Licensing Agreement with Knight Therapeutics 11
3D Signatures Raises USD1.3 Million in Private Placement of Units 12
3D Signatures Raises USD0.4 Million in Private Placement of Shares 13
3D Signatures Raises USD0.3 Million in Third and Final Tranche of Private Placement of Units 14
3D Signatures Raises Funds through Second Tranche of Private Placement of Units 16
3D Signatures Raises USD0.7 Million in Private Placement of Shares 18
Plicit Capital Acquires 3D Signatures in Reverse Takeover Transaction 19
3D Signatures Inc, Key Competitors 20
3D Signatures Inc, Key Employees 21

List of Figures
3D Signatures Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
3D Signatures Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
3D Signatures Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
3D Signatures Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
3D Signatures Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
3D Signatures Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
3D Signatures Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
3D Signatures Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[3D Signatures Inc (DXD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Regeneron Pharmaceuticals Inc (REGN):企業の財務・戦略的SWOT分析
    Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DexCom Inc (DXCM)-医療機器分野:企業M&A・提携分析
    Summary DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring syst …
  • MedX Health Corp (MDX):企業の財務・戦略的SWOT分析
    Summary MedX Health Corp (MedX) is a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser probe, and …
  • Earthstone Energy Inc (ESTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Earthstone Energy Inc (Earthstone Energy), formerly Basic Earth Science Systems Inc is an independent oil and gas company that offers acquisition, exploration, production and development of oil and gas properties. The company's activities include acquiring, drilling, developing and producing …
  • Identiv Inc (INVE):企業の財務・戦略的SWOT分析
    Summary Identiv Inc (Identiv), formerly Identive Group Inc, is a technology company that offers physical security and secure identification solutions. The company’s products include trusted authentication solutions, identity solutions, physical access control solutions, premises access solutions, co …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • C’Bon Cosmetics Co Ltd:企業の戦略・SWOT・財務分析
    C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report Summary C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Impact Developer & Contractor SA:企業の戦略・SWOT・財務情報
    Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report Summary Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • UCB S.A.:企業のM&A・事業提携・投資動向
    UCB S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • Patrys Ltd (PAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Patrys Ltd (Patrys) is a therapeutic antibody development company focused on IgM antibodies and IgG antibody fragments in the field of oncology. The company's pipeline products include PAT-SC1 an immunoglobulin M (IgM) type antibody used for the treatment of gastric cancer; PAT-SM6 is a full …
  • Blue Moon Zinc Corp.:企業の戦略・SWOT・財務情報
    Blue Moon Zinc Corp. - Strategy, SWOT and Corporate Finance Report Summary Blue Moon Zinc Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Rigel Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Volga Gas plc (VGAS):企業の財務・戦略的SWOT分析
    Summary Volga Gas Plc (Volga Gas) is an oil and gas company that provides oil and gas exploration and production services. The company acquires, produces and develops oil, natural gas deposit properties, and others. It owns and operates oil and gas producing assets in Karpenskiy licence area, Pre-Ca …
  • Oldenburgische Landesbank AG:企業の戦略・SWOT・財務分析
    Oldenburgische Landesbank AG - Strategy, SWOT and Corporate Finance Report Summary Oldenburgische Landesbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Patterson Companies, Inc.
    Patterson Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Patterson Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Societe Generale Private Banking:企業の戦略・SWOT・財務分析
    Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report Summary Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • The Goldman Sachs Group Inc (GS):企業の財務・戦略的SWOT分析
    The Goldman Sachs Group Inc (GS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hobby Lobby Stores Inc:戦略・SWOT・企業財務分析
    Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Utah Medical Products Inc (UTMD):企業の財務・戦略的SWOT分析
    Summary Utah Medical Products Inc (Utah Medical) is a medical device company that offers disposable and reusable products. The company offers blood pressure monitoring and blood management, gynecology, perinatology, urology and electrosurgery, respiratory and OEM products. Its blood pressure monitor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆